4.5 Article

THE INTERACTION OF DISRUPTED TYPE II NEUREGULIN 1 AND CHRONIC ADOLESCENT STRESS ON ADULT ANXIETY- AND FEAR-RELATED BEHAVIORS

Journal

NEUROSCIENCE
Volume 249, Issue -, Pages 31-42

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2012.09.045

Keywords

neuregulin; HPA axis; sex difference; elevated plus maze; fear conditioning; reactivity

Categories

Funding

  1. NIDA [N01DA59909]
  2. NIMH [R01MH73826, P50MH82999]

Ask authors/readers for more resources

The incidence of anxiety, mood, substance abuse disorders and schizophrenia increases during adolescence. Epidemiological evidence confirms that exposure to stress during sensitive periods of development can create vulnerabilities that put genetically predisposed individuals at increased risk for psychiatric disorders. Neuregulin I (NRG1) is a frequently identified schizophrenia susceptibility gene that has also been associated with the psychotic features of bipolar disorder. Previously, we established that Type ll NRG1 is expressed in the hypothalamic pituitary adrenal (HPA) axis neurocircuitry. We also found, using a line of Nrg1 hypomorphic rats (Nrg1 (TM)), that genetic disruption of Type II NRG1 results in altered HPA axis function and environmental reactivity. The present studies used the Nrg1 (TM) rats to test whether Type ll NRG1 gene disruption and chronic stress exposure during adolescence interact to alter adult anxiety- and fear-related behaviors. Male and female Nrg1 (TM) and wild-type rats were exposed to chronic variable stress (CVS) during mid-adolescence and then tested for anxiety-like behavior, cued fear conditioning and basal corticosterone secretion in adulthood. The disruption of Type II NRG1 alone significantly impacts rat anxiety-related behavior by reversing normal sex-related differences and impairs the ability to acquire cued fear conditioning. Sex-specific interactions between genotype and adolescent stress also were identified such that CVS-treated wild-type females exhibited a slight reduction in anxiety-like behavior and basal corticosterone, while CVS-treated Nrg1 (TM) females exhibited a significant increase in cued fear extinction. These studies confirm the importance of Type II NRG1 in anxiety and fear behaviors and point to adolescence as a time when stressful experiences can shape adult behavior and HPA axis function. This article is part of a Special Issue entitled: Stress and the Adolescent Brain. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cell Biology

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits

P. Darrell Neufer, Marcas M. Bamman, Deborah M. Muoio, Claude Bouchard, Dan M. Cooper, Bret H. Goodpaster, Frank W. Booth, Wendy M. Kohrt, Robert E. Gerszten, Mark P. Mattson, Russell T. Hepple, William E. Kraus, Michael B. Reid, Sue C. Bodine, John M. Jakicic, Jerome L. Fleg, John P. Williams, Lyndon Joseph, Mary Evans, Padma Maruvada, Mary Rodgers, Mary Roary, Amanda T. Boyce, Jonelle K. Drugan, James I. Koenig, Richard H. Ingraham, Danuta Krotoski, Mary Garcia-Cazarin, Joan A. McGowan, Maren R. Laughlin

CELL METABOLISM (2015)

Article Psychiatry

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Kathryn L. Ossenfort, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Article Psychiatry

Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, Sara K. Sullivan, James M. Gold, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Article Psychiatry

Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia

Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Katherine H. Frost, Robert W. Buchanan

SCHIZOPHRENIA RESEARCH (2015)

Review Cell Biology

The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline

Roderick A. Corriveau, Francesca Bosetti, Marian Emr, Jordan T. Gladman, James I. Koenig, Claudia S. Moy, Katherine Pahigiannis, Salina P. Waddy, Walter Koroshetz

CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Small Blood Vessels: Big Health Problems?: Scientific Recommendations of the National Institutes of Health Workshop

Francesca Bosetti, Zorina S. Galis, Margaret S. Bynoe, Marc Charette, Marilyn J. Cipolla, Gregory J. del Zoppo, Douglas Gould, Thomas S. Hatsukami, Teresa L. Z. Jones, James I. Koenig, Gerard A. Lutty, Christine Maric-Bilkan, Troy Stevens, H. Eser Tolunay, Walter Koroshetz

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Article Clinical Neurology

Translational Stroke Research Vision and Opportunities

Francesca Bosetti, James I. Koenig, Cenk Ayata, Stephen A. Back, Kyra Becker, Joseph P. Broderick, S. Thomas Carmichael, Sunghee Cho, Marilyn J. Cipolla, Dale Corbett, Roderick A. Corriveau, Steven C. Cramer, Adam R. Ferguson, Seth P. Finklestein, Byron D. Ford, Karen L. Furie, Thomas M. Hemmen, Costantino Iadecola, Lyn B. Jakeman, Scott Janis, Edward C. Jauch, Karen C. Johnston, Patrick M. Kochanek, Harold Kohn, Eng H. Lo, Patrick D. Lyden, Carina Mallard, Louise D. McCullough, Linda M. McGavern, James F. Meschia, Claudia S. Moy, Miguel A. Perez-Pinzon, Ipolia Ramadan, Sean I. Savitz, Lee H. Schwamm, Gary K. Steinberg, Mary P. Stenzel-Poore, Michael Tymianski, Steven Warach, Lawrence R. Wechsler, John H. Zhang, Walter Koroshetz

STROKE (2017)

Review Clinical Neurology

A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations

Veronica Schiariti, Eileen Fowler, Joline E. Brandenburg, Eric Levey, Sarah Mcintyre, Theresa Sukal-Moulton, Sharon L. Ramey, Jessica Rose, Susan Sienko, Elaine Stashinko, Laura Vogtle, Robin S. Feldman, James I. Koenig

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)

Article Clinical Neurology

Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia

Christina A. Wilson, James I. Koenig

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)

Article Clinical Neurology

Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset

Alyssa M. Day, Adrienne M. Hammill, Csaba Juhasz, Anna L. Pinto, E. Steve Roach, Charles E. McCulloch, Anne M. Comi, Karen L. Ball, Brian J. Fisher, Jim Koenig, Michael T. Lawton, Warren D. Lo, Douglas A. Marchuk, Daniel K. Miles, Marsha A. Moses, Angus A. Wilfong

PEDIATRIC NEUROLOGY (2019)

Article Psychiatry

Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia

Gregory P. Strauss, Hannah C. Chapman, William R. Keller, James I. Koenig, James M. Gold, William T. Carpenter, Robert W. Buchanan

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

Editorial Material Clinical Neurology

Organizational Update: The NINDS-Sponsored Stroke Preclinical Assessment Network Is Moving to Its Next Stage

Francesca Bosetti, James Koenig, L. Scott Janis, Clinton B. Wright

STROKE (2021)

Article Clinical Neurology

The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results

Patrick D. Lyden, Francesca Bosetti, Marcio A. Diniz, Andre Rogatko, James Koenig, Jessica Lamb, Karisma A. Nagarkatti, Ryan P. Cabeen, David C. Hess, Pradip K. Kamat, Mohammad B. Khan, Kristofer Wood, Krishnan Dhandapani, Ali S. Arbab, Enrique C. Leira, Anil K. Chauhan, Nirav Dhanesha, Rakesh B. Patel, Mariia Kumskova, Daniel Thedens, Andreia Morais, Takahiko Imai, Tao Qin, Cenk Ayata, Ligia S. B. Boisserand, Alison L. Herman, Hannah E. Beatty, Sofia E. Velazquez, Sebastian Diaz-Perez, Basavaraju G. Sanganahalli, Jelena M. Mihailovic, Fahmeed Hyder, Lauren H. Sansing, Raymond C. Koehler, Steven Lannon, Yanrong Shi, Senthilkumar S. Karuppagounder, Adnan Bibic, Kazi Akhter, Jaroslaw Aronowski, Louise D. McCullough, Anjali Chauhan, Andrew Goh

Summary: Cerebral ischemia and reperfusion lead to neurological disabilities, and developing successful stroke treatments has been challenging. The Stroke Preclinical Assessment Network (SPAN) aims to reduce bias in treatment selection for clinical studies by rigorously assessing candidate treatments across multiple research laboratories. The first stage of SPAN successfully implemented standardized procedures, randomization, and blinded assessment. Subsequent stages will evaluate candidate treatments using aged animals and animals with comorbid conditions.

STROKE (2022)

Article Clinical Neurology

Embracing Heterogeneity in The Multicenter Stroke Preclinical Assessment Network (SPAN) Trial

Andreia Morais, Joseph J. J. Locascio, Lauren H. H. Sansing, Jessica Lamb, Karisma Nagarkatti, Takahiko Imai, Klaus van Leyen, Jaroslaw Aronowski, James I. I. Koenig, Francesca Bosetti, Patrick Lyden, Cenk Ayata, SPAN Investigators

Summary: The Stroke Preclinical Assessment Network (SPAN) is a multicenter preclinical trial platform that uses rodent models of transient focal cerebral ischemia to address translational failure in experimental stroke. In this study, we report the heterogeneity introduced by allowing variations in biological and experimental model variables among the 6 SPAN laboratories and its impact on middle cerebral artery occlusion (MCAo) performance.

STROKE (2023)

Editorial Material Clinical Neurology

Organizational Update: The NINDS Reperfusion Research Pipeline

Clinton B. Wright, Francesca Bosetti, James I. Koenig, L. Scott Janis

STROKE (2023)

Article Neurosciences

Human Placenta Derived Mesenchymal Stem Cells Transplantation Reducing Cellular Apoptosis in Hypoxic-Ischemic Neonatal Rats by Down-Regulating Semaphorin 3A/Neuropilin-1

Yang He, Jun Tang, Meng Zhang, Junjie Ying, Dezhi Mu

Summary: This study investigated the protective effects and mechanisms of human placenta derived mesenchymal stem cells (hPMSCs) transplantation in a rat model of hypoxic-ischemic encephalopathy (HIE). The results showed that hPMSCs transplantation reduced apoptosis and improved long-term neurological prognosis. Furthermore, the downregulation of Sema 3A/NRP-1 expression and activation of the PI3K/Akt/mTOR signaling pathway played a key role in the protective effects of hPMSCs.

NEUROSCIENCE (2024)

Article Neurosciences

Probing the Neurophysiology of Temporal Sensitivity in the Somatosensory System Using the Mismatch Negativity (MMN) Sensory Memory Paradigm

Emily L. Isenstein, Edward G. Freedman, Jiayi Xu, Ian A. DeAndrea-Lazarus, John J. Foxe

Summary: This study evaluated electrophysiological discrimination of parametric somatosensory stimuli in healthy young adults to understand how the brain processes the duration of tactile information. The results showed that participants did not electrophysiologically discriminate between 100 and 115 ms, but they exhibited distinct electrophysiological responses when the deviant stimuli were 130, 145, and 160 ms. These findings contribute to a better understanding of tactile sensitivity in different clinical conditions.

NEUROSCIENCE (2024)

Article Neurosciences

Enhancement of the Evoked Excitatory Transmission in the Nucleus Tractus Solitarius Neurons after Sustained Hypoxia in Mice Depends on A2A Receptors

Juliana R. Souza, Ludmila Lima-Silveira, Daniela Accorsi-Mendonca, Benedito H. Machado

Summary: This study demonstrates that A2A receptors play a crucial role in modulating synaptic transmission in the NTS neurons and are required for the enhancement of glutamatergic transmission observed under short-term sustained hypoxia conditions.

NEUROSCIENCE (2024)

Article Neurosciences

Correlation Between Cued Fear Memory Retrieval and Oscillatory Network Inhibition in the Amygdala Is Disrupted by Acute REM Sleep Deprivation

Miki Hashizume, Rina Ito, Rie Suge, Yasushi Hojo, Gen Murakami, Takayuki Murakoshi

Summary: The basolateral amygdaloid complex (BLA) is closely involved in the formation of emotional memories, including both aversive memory and contextual fear memory. Acute sleep deprivation (SD) disrupts the acquisition of tone-associated fear memory in juvenile rats, but has no significant effect on contextual fear memory. Slow network oscillation in the amygdala contributes to the formation of amygdala-dependent fear memory in relation to sleep.

NEUROSCIENCE (2024)

Article Neurosciences

Enhanced Gasdermin-E-mediated Pyroptosis in Alzheimer's Disease

Qunxian Wang, Shipeng Guo, Dongjie Hu, Xiangjun Dong, Zijun Meng, Yanshuang Jiang, Zijuan Feng, Weihui Zhou, Weihong Song

Summary: GSDME plays a crucial role in the pathogenesis of Alzheimer's disease by regulating the switch from apoptosis to pyroptosis and participating in neuroinflammatory response. Knockdown of GSDME has been shown to improve cognitive impairments, indicating that GSDME could be a therapeutic target for Alzheimer's disease.

NEUROSCIENCE (2024)